When is a lump worth worrying about? What raises and lowers the concern
Most lumps are not cancer — swollen glands usually signal infection, and most breast changes are benign. A few features shift the calculus: hard, fixed, growing, or paired with night sweats or weight loss.
Finding a lump is one of the most common reasons people fear cancer, and one of the most common ways that fear turns out to be misplaced. The great majority of lumps are not cancer. But "most are benign" is not the same as "ignore it," and the useful skill is knowing which features tip a lump from reassuring toward worth-checking.
What a lump usually is, by location
The lumps people notice most often are swollen lymph nodes — the small glands felt in the neck, under the jaw and chin, behind the ears, in the armpit and in the groin. Infections are the most common cause of swollen lymph nodes, from a cold or sore throat to a dental abscess or skin infection [s1]. A tender node that appears with a cold and settles over a week or two is behaving exactly as a node should.
Breast lumps prompt similar worry and are also usually benign. A variety of benign — not cancer — conditions can cause lumps or lumpiness in the breast, including fluid-filled cysts that are most common in premenopausal women and can be tender just before a period [s2]. In the testicle, the picture is different in one important way: testicular cancer often causes a painless lump, so a firm lump there is worth prompt assessment even without pain or other symptoms [s3].
The features that raise concern
Across sites, a similar short list of features shifts a lump toward needing evaluation. For a lymph node, reasons to contact a health professional include a node that does not get smaller after several weeks or keeps getting larger; one that feels hard, irregular or fixed in place; or swelling accompanied by fever, night sweats or unexplained weight loss [s1]. Those systemic symptoms — drenching night sweats, weight loss without trying — matter because they can signal that a lump is more than local.
Texture and mobility carry information too. A soft, tender lump that moves under the fingers and fluctuates is more often benign; a hard, painless lump fixed to the surrounding tissue is the pattern that warrants a closer look [s1]. On examination, a doctor checking the testicle is feeling for a firm mass within it, distinct from the softer structures around it [s3]. In a child, any lymph node larger than 1 centimetre — about 0.4 inch — is a reason to seek advice [s1].
The features that lower it
Reassuring signs are worth stating plainly, because they describe most lumps. A lump that is painful or tender, appears alongside an obvious infection, comes and goes with the menstrual cycle, or shrinks over days to weeks is behaving in a way that points away from cancer [s1][s2]. None of this is a substitute for examination, but it is why clinicians do not treat every lump as an emergency.
What this means for a reader
The honest summary is that a new lump is common, usually harmless, and still worth mentioning to a doctor if it does not resolve. The clearest reasons to get one checked without delay are a lump that is hard, painless and does not move; one that keeps growing or has not gone after a few weeks; a painless lump in a testicle; or any lump that comes with unexplained weight loss, fever or night sweats [s1][s2][s3]. A lump cannot be reliably self-diagnosed as benign — the point of the visit is that a doctor can examine it and, where needed, image or biopsy it. Waiting a couple of weeks to see whether an obviously infection-linked, tender node settles is reasonable; watching a hard, growing, painless lump for months is not.
Sources
- Swollen lymph nodes — MedlinePlus (US National Library of Medicine) , January 14, 2026
- Breast Changes and Conditions: A Health Guide — National Cancer Institute , December 2, 2025
- Testicular cancer — MedlinePlus (US National Library of Medicine) , May 1, 2026
More on
FDA approves tucatinib to maintain control of HER2-positive breast cancer
The pill joins trastuzumab and pertuzumab as maintenance after induction. In the 654-patient HER2CLIMB-05 trial it stretched median progression-free survival to 24.9 months from 16.3, a hazard ratio of 0.64.
Night shift work is a 'probable' carcinogen. The human evidence remains far from settled
The IARC calls night shift work probably carcinogenic. A 2026 meta-analysis of nurses shows why 'probably' is careful: the breast cancer signal appears only after decades, and shrinks to nothing once bias is corrected.
Alcohol causes cancer at every level of drinking. Most people do not know it.
A 2025 US Surgeon General advisory put alcohol third among preventable causes of cancer. The global data show light drinking contributes too, not only heavy use.
A GBD study attributes 48,307 breast-cancer deaths in 2023 to high blood sugar
A Global Burden of Disease analysis finds the share of female breast-cancer deaths tied to high fasting plasma glucose rose from 1990 to 2023 and is projected to keep rising — but the design cannot prove causation.